Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential pharmacokinetic study of posaconazole oral suspension and tablets in high-risk hematology patients
2015-003940-38Phase 4Active
- Sponsor
- Fundación de Investigación Biomédica Hospital Puerta de Hierro
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of posaconazole in invasive mycoses, sponsored by Fundación de Investigación Biomédica Hospital Puerta de Hierro. Primary endpoint: Comparison of pharmacokinetic profile of posaconazole oral suspension and solid tablets. Started Jan 2016; status: active.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2015-003940-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003940-38.